Provided by Tiger Trade Technology Pte. Ltd.

Quanterix Corp

3.40
-0.2000-5.56%
Post-market: 3.410.0100+0.29%19:07 EDT
Volume:1.14M
Turnover:3.98M
Market Cap:158.82M
PE:-1.35
High:3.66
Open:3.60
Low:3.37
Close:3.60
52wk High:8.77
52wk Low:3.24
Shares:46.71M
Float Shares:37.82M
Volume Ratio:1.19
T/O Rate:3.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5130
EPS(LYR):-2.5130
ROE:-34.25%
ROA:-13.11%
PB:0.54
PE(LYR):-1.35

Loading ...

Quanterix debuts Content Innovation Engine at AACR 2026

TIPRANKS
·
Apr 15

Quanterix to debut Content Innovation Engine at AACR Annual Meeting

Reuters
·
Apr 15

Quanterix sets 2026 annual shareholder meeting date; proposal and nomination submission deadline moves to April 6, 2026

Reuters
·
Mar 28

Quanterix Chief Legal Officer Daniel Char files initial beneficial ownership statement

Reuters
·
Mar 25

Quanterix files Form 3 initial beneficial ownership statement for COO Michael Francis Miller

Reuters
·
Mar 18

Quanterix Faces Significant Supply Chain Risk From Single-Source Instrument Manufacturers

TIPRANKS
·
Mar 04

Quanterix Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 03

Quanterix Q4 Adj. EPS $(0.47) Misses $(0.45) Estimate, Sales $43.855M Beat $38.139M Estimate

Benzinga
·
Mar 03

Quanterix reports Q4 EPS (49c) vs. (30c) last year

TIPRANKS
·
Mar 03

Quanterix sees FY26 revenue $169M-$174M, consensus $168.8M

TIPRANKS
·
Mar 03

Quanterix Q4 revenue rises 25% to USD 43.9 million

Reuters
·
Mar 03

BRIEF-Quanterix Q4 Net Income USD -23.117 Million

Reuters
·
Mar 03

Quanterix Q4 Operating Expenses USD 44.789 Million

THOMSON REUTERS
·
Mar 03

Quanterix Corp: Expects to Achieve Cash Flow Breakeven Performance in Second Half

THOMSON REUTERS
·
Mar 03

Quanterix Lucent Diagnostics Partners With Life Line Screening for Nationwide Blood Biomarker Testing

Reuters
·
Mar 02

Quanterix Corp expected to post a loss of 45 cents a share - Earnings Preview

Reuters
·
Feb 28

Quanterix Executive Team to Participate in Upcoming March Investor Conferences

Reuters
·
Feb 26

Press Release: Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026

Dow Jones
·
Feb 20

Quanterix Corporation Schedules Conference Call to Discuss Fourth-Quarter and Full-Year Financial Results

Reuters
·
Feb 20

Quanterix Submits FDA 510(k) Application for Multi-Analyte Blood Test for Alzheimer's Detection

Reuters
·
Feb 03